Skip to content

A verification study of the improvement effects of the test food on mouth dryness

The effects of the test food on the mouth dryness in healthy Japanese subjects: a randomized, double-blind, placebo-controlled, parallel-group trial - The effects of the test food on the mouth dryness in healthy Japanese subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038554
Enrollment
52
Registered
2019-11-12
Start date
2019-11-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese subjects

Interventions

Duration: 8 weeks Test food: Test food Administration: Take 1 tablet, three times a day. * If you forget to take the tablet, take it as soon as you remember within the day. Duration: 8 weeks Tes

Sponsors

ORTHOMEDICO Inc.
Lead Sponsor
Medical Corporation Seishinkai, Takara Clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy Japanese adult subjects 2. Subjects who feel thirsty in the mouth 3. Subjects who are judged as ineligible to participate in the study by the physician 4. Subjects whose saliva test (Saxon test) is 2 g or more in 2 minutes 5. Subjects whose oral moisture level [using Mucus (R)] is relatively low 6. Subjects whose VAS values of subjective mouth dryness is relatively high

Exclusion criteria

Exclusion criteria: Subjects who 1. are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2. have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. are undergoing medical treatment or have a medical history of a salivary gland disorder (including sialadenitis, sialolithiasis, Sjogren's syndrome, and salivary gland tumors), or Subjects who removed a salivary gland 4. are undergoing medical treatment of autoimmune disease 5. are currently undergoing treatment for the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, and/or any other chronic diseases 6. use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily 7. are currently taking medicines (include herbal medicines) and supplements 8. buy more than 2 packs of 9 chewing gum sheets or 14 to 20 chewing gum a month, or eat about 40 chewing gum a month 9. are smokers 10. use implants, tooth caps, dentures, and bridges 11. have received treatment of periodontosis or with antimicrobial drugs (including antibacterial drugs) within the last three months 12. have receiving dental maintenance care, such as removing dental plaques and dental tartars within the last three months 13. are under treatment or diagnosed with any of dental diseases 14. regularly use floss, interdental cleaner, and mouthwash 15. are allergic to medicines and/or the test food related products 16. are pregnant, lactation, or planning to become pregnant 17. have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to participate another trial during this trial 18. are judged as ineligible to participate in the study by the physician

Design outcomes

Primary

MeasureTime frame
The amount of changes of visual analogue scale (VAS) values of subjective mouth dryness between at screening (before test-food consumption; Scr) and 8 weeks after the start of test-food consumption (8w)

Secondary

MeasureTime frame
1. The amount of changes of VAS values in the subjective symptom of mouth dryness between at Scr and 4 weeks after the start of test-food consumption (4w) 2. The amount of changes in the following items between at Scr and 4w, and 8w VAS values of subjective symptoms of longing for drinking, difficulty eating and oral consistency; the volume of saliva; salivary amylase concentration; oral moisture values; and volatile sulfur compounds in the oral cavity 3. The logarithmic transformation values or the amount of changes in the following items between at Scr and 4w, and 8w Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola 4. The ratio of subjects whose measured VAS values of subjective mouth dryness at 8w decreasing by 50% or more compared to Scr. 5. The ratio of subjects whose measured VAS values of subjective mouth dryness at 8w decreasing by 25% or more compared to Scr. 6. The ratio of subjects whose oral moisture level 8w decreasing compared to Scr. 7. The ratio of subjects whose oral moisture values at 8w is 28.0 or more.

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026